Cargando…
Vancomycin therapy in critically ill patients on continuous renal replacement therapy; are we doing enough?
BACKGROUND: Recommendations regarding vancomycin dosing and monitoring in critically ill patients on continuous renal replacement therapy (CRRT) are limited. This is a retrospective study to assess the adequacy of current vancomycin dosing and monitoring practice for patients on CRRT in a tertiary h...
Autores principales: | Omrani, Ali S., Mously, Alaa, Cabaluna, Marylie P., Kawas, John, Albarrak, Mohammed M., Alfahad, Wafa A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4475842/ https://www.ncbi.nlm.nih.gov/pubmed/26106281 http://dx.doi.org/10.1016/j.jsps.2014.08.005 |
Ejemplares similares
-
Severe hypophosphatemia in the critically ill: are we replacing enough?
por: Millwood Hargrave, J, et al.
Publicado: (2015) -
Testosterone Replacement Therapy in Men with Untreated or Treated Prostate Cancer: Do We Have Enough Evidences?
por: Kim, Myong, et al.
Publicado: (2021) -
High dose intravenous colistin methanesulfonate therapy is associated with high rates of nephrotoxicity; a prospective cohort study from Saudi Arabia
por: Omrani, Ali S, et al.
Publicado: (2015) -
Regulation of nanotechnology: Are we doing enough?
por: Webster, Thomas J
Publicado: (2007) -
Informed consent: Are we doing enough?
por: Pranati,
Publicado: (2010)